Skip to main content
. Author manuscript; available in PMC: 2014 Jun 27.
Published in final edited form as: Cancer Biol Ther. 2010 Jan 28;9(1):66–76. doi: 10.4161/cbt.9.1.10451

Table 1.

BRCA1/ER/PR/HER2 Status of Breast Cancer Cell Lines

ER PR HER2/neu BRCA1 Mutation
Status
BRCA1* gamma-tubulin
level/cell
% soluble
gamma-tubulin
MCF-10A WT NA ++ 51.9
BT-20 + WT + + 56.1
SKBR3 ++ WT ++ + 62.8
BT-549 WT ++ +++ 70.9
MCF-7 + + +/− WT +/− + 55.1
BT-474 + + ++ WT ++ + 73.8
MDA-MB-436 5396 + 1G > A ++** ++ 63.4
Hs578T +/− WT ++ +++ 78.9
MDA-MB-231 +/− WT ++ +++ 68.4
HCC1428 + + NA + 70.3
HCC1937 5382insC ++ ++++ 70.9
*

++ normal transcript levels, + low transcript levels, +/− barely detectable levels

**

different length transcripts

NA data not available

− negative, +/− low, + normal, ++ overexpression

+ low, ++ medium, +++ high, ++++ very high